Specifications
| Publisher | John Wiley And Sons Ltd |
| ISBN 13 | 9781118488133 |
| Book Subtitle | A Guide For Medicinal Chemists And Pharmacologists |
| Book Description | With enzymes being the most valued and common of drug targets, an understanding of their interactions with inhibitors is critical to successful drug discovery. Now in a second edition, this proven work clearly explains the biochemical data and experimental details underlying the science, arming medicinal chemists and pharmacologists with the tools they need to master the art of applied enzymology for drug discovery. With updated material throughout, two new chapters, and five new appendices, Evaluation of Enzyme Inhibitors in Drug Discovery, Second Edition remains the only book available on the topic. |
| About the Author | Robert a. Copeland, phd, is executive vice president and chief scientific officer at epizyme, inc., A biopharmaceutical company in cambridge, massachusetts. He is on the editorial board of the journal of biological chemistry and a member of the faculty of 1000. Dr. Copeland has contributed more than 175 publications to the scientific literature and holds eight u.S.-Issued patents. He has authored several books in protein science and enzymology, including enzymes: a practical introduction to structure, mechanism, and data analysis, second edition (wiley). |
| Language | English |
| Author | Robert A. Copeland |
| Edition Number | 2 |
| Publication Date | 18 Mar 2013 |
| Number of Pages | 572 |
Evaluation Of Enzyme Inhibitors In Drug Discovery: A Guide For Medicinal Chemists And Pharmacologists hardcover english - 18 Mar 2013
Added to cart
Cart Total SAR 0.00
